Vulvar cancer in young women: demographic features and outcome evaluation

Grainger S. Lanneau, Peter A. Argenta, Marion S. Lanneau, Robert H. Riffenburgh, Michael A. Gold, D. Scott McMeekin, Nancy Webster, Patricia L. Judson

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objective: The objective of the study was to identify prognostic and environmental factors associated with vulvar carcinoma in young women. Study Design: This study was a review of patients younger than 45 years who were diagnosed with vulvar squamous cell carcinoma between 1994 and 2006. Results: Fifty-six patients were identified. Median age was 38 years and median follow-up was 25.3 months. Fifty-eight percent of patients presented with stage I disease; 77% smoked tobacco. Of patients with advanced disease, 53.3% were smokers, 40% had human papillomavirus (HPV) exposure, 46.7% had a history of vulvar intraepithelial neoplasia (VIN), and 6.7% were immunocompromised. Symptoms were present for more than 12 months in 47%, but symptom duration did not correlate with stage (P = .42) or positive lymph nodes (P = .28). Disease recurred in 10.7% and 5.4% died of disease. Conclusion: Young women with vulvar cancer tend to have early-stage disease, smoke, have a history of HPV, and have VIN. Many of the factors that place these patients at continuous risk are modifiable.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume200
Issue number6
DOIs
StatePublished - Jun 1 2009

Fingerprint

Vulvar Neoplasms
Demography
Smoke
Tobacco
Squamous Cell Carcinoma
Neoplasms
Lymph Nodes
Carcinoma

Keywords

  • Demographic
  • outcome
  • vulvar cancer
  • young

Cite this

Lanneau, G. S., Argenta, P. A., Lanneau, M. S., Riffenburgh, R. H., Gold, M. A., McMeekin, D. S., ... Judson, P. L. (2009). Vulvar cancer in young women: demographic features and outcome evaluation. American Journal of Obstetrics and Gynecology, 200(6). https://doi.org/10.1016/j.ajog.2009.01.014

Vulvar cancer in young women : demographic features and outcome evaluation. / Lanneau, Grainger S.; Argenta, Peter A.; Lanneau, Marion S.; Riffenburgh, Robert H.; Gold, Michael A.; McMeekin, D. Scott; Webster, Nancy; Judson, Patricia L.

In: American Journal of Obstetrics and Gynecology, Vol. 200, No. 6, 01.06.2009.

Research output: Contribution to journalArticle

Lanneau, GS, Argenta, PA, Lanneau, MS, Riffenburgh, RH, Gold, MA, McMeekin, DS, Webster, N & Judson, PL 2009, 'Vulvar cancer in young women: demographic features and outcome evaluation', American Journal of Obstetrics and Gynecology, vol. 200, no. 6. https://doi.org/10.1016/j.ajog.2009.01.014
Lanneau, Grainger S. ; Argenta, Peter A. ; Lanneau, Marion S. ; Riffenburgh, Robert H. ; Gold, Michael A. ; McMeekin, D. Scott ; Webster, Nancy ; Judson, Patricia L. / Vulvar cancer in young women : demographic features and outcome evaluation. In: American Journal of Obstetrics and Gynecology. 2009 ; Vol. 200, No. 6.
@article{71f4e2a0a46442f59dedd3cee1a1f2d1,
title = "Vulvar cancer in young women: demographic features and outcome evaluation",
abstract = "Objective: The objective of the study was to identify prognostic and environmental factors associated with vulvar carcinoma in young women. Study Design: This study was a review of patients younger than 45 years who were diagnosed with vulvar squamous cell carcinoma between 1994 and 2006. Results: Fifty-six patients were identified. Median age was 38 years and median follow-up was 25.3 months. Fifty-eight percent of patients presented with stage I disease; 77{\%} smoked tobacco. Of patients with advanced disease, 53.3{\%} were smokers, 40{\%} had human papillomavirus (HPV) exposure, 46.7{\%} had a history of vulvar intraepithelial neoplasia (VIN), and 6.7{\%} were immunocompromised. Symptoms were present for more than 12 months in 47{\%}, but symptom duration did not correlate with stage (P = .42) or positive lymph nodes (P = .28). Disease recurred in 10.7{\%} and 5.4{\%} died of disease. Conclusion: Young women with vulvar cancer tend to have early-stage disease, smoke, have a history of HPV, and have VIN. Many of the factors that place these patients at continuous risk are modifiable.",
keywords = "Demographic, outcome, vulvar cancer, young",
author = "Lanneau, {Grainger S.} and Argenta, {Peter A.} and Lanneau, {Marion S.} and Riffenburgh, {Robert H.} and Gold, {Michael A.} and McMeekin, {D. Scott} and Nancy Webster and Judson, {Patricia L.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.ajog.2009.01.014",
language = "English (US)",
volume = "200",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Vulvar cancer in young women

T2 - demographic features and outcome evaluation

AU - Lanneau, Grainger S.

AU - Argenta, Peter A.

AU - Lanneau, Marion S.

AU - Riffenburgh, Robert H.

AU - Gold, Michael A.

AU - McMeekin, D. Scott

AU - Webster, Nancy

AU - Judson, Patricia L.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Objective: The objective of the study was to identify prognostic and environmental factors associated with vulvar carcinoma in young women. Study Design: This study was a review of patients younger than 45 years who were diagnosed with vulvar squamous cell carcinoma between 1994 and 2006. Results: Fifty-six patients were identified. Median age was 38 years and median follow-up was 25.3 months. Fifty-eight percent of patients presented with stage I disease; 77% smoked tobacco. Of patients with advanced disease, 53.3% were smokers, 40% had human papillomavirus (HPV) exposure, 46.7% had a history of vulvar intraepithelial neoplasia (VIN), and 6.7% were immunocompromised. Symptoms were present for more than 12 months in 47%, but symptom duration did not correlate with stage (P = .42) or positive lymph nodes (P = .28). Disease recurred in 10.7% and 5.4% died of disease. Conclusion: Young women with vulvar cancer tend to have early-stage disease, smoke, have a history of HPV, and have VIN. Many of the factors that place these patients at continuous risk are modifiable.

AB - Objective: The objective of the study was to identify prognostic and environmental factors associated with vulvar carcinoma in young women. Study Design: This study was a review of patients younger than 45 years who were diagnosed with vulvar squamous cell carcinoma between 1994 and 2006. Results: Fifty-six patients were identified. Median age was 38 years and median follow-up was 25.3 months. Fifty-eight percent of patients presented with stage I disease; 77% smoked tobacco. Of patients with advanced disease, 53.3% were smokers, 40% had human papillomavirus (HPV) exposure, 46.7% had a history of vulvar intraepithelial neoplasia (VIN), and 6.7% were immunocompromised. Symptoms were present for more than 12 months in 47%, but symptom duration did not correlate with stage (P = .42) or positive lymph nodes (P = .28). Disease recurred in 10.7% and 5.4% died of disease. Conclusion: Young women with vulvar cancer tend to have early-stage disease, smoke, have a history of HPV, and have VIN. Many of the factors that place these patients at continuous risk are modifiable.

KW - Demographic

KW - outcome

KW - vulvar cancer

KW - young

UR - http://www.scopus.com/inward/record.url?scp=67349282349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349282349&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2009.01.014

DO - 10.1016/j.ajog.2009.01.014

M3 - Article

C2 - 19286150

AN - SCOPUS:67349282349

VL - 200

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -